Principal Financial Group Inc Charles River Laboratories International, Inc. Transaction History

Principal Financial Group Inc

  • $160 Billion
  • Q2 2024

A detailed history of Principal Financial Group Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 58,375 shares of CRL stock, worth $11.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
58,375
Previous 172,722 66.2%
Holding current value
$11.6 Million
Previous $46.8 Million 74.23%
% of portfolio
0.01%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
SELL
$206.39 - $268.73 $23.6 Million - $30.7 Million
-114,347 Reduced 66.2%
58,375 $12.1 Million
Q1 2024

Apr 29, 2024
BUY
$203.52 - $273.43 $4.11 Million - $5.52 Million
20,185 Added 13.23%
172,722 $46.8 Million
Q4 2023

Feb 07, 2024
BUY
$164.52 - $238.84 $5.91 Million - $8.58 Million
35,921 Added 30.8%
152,537 $36.1 Million
Q3 2023

Nov 02, 2023
SELL
$194.44 - $217.61 $354,269 - $396,485
-1,822 Reduced 1.54%
116,616 $22.9 Million
Q2 2023

Aug 07, 2023
SELL
$183.71 - $210.25 $5.33 Million - $6.09 Million
-28,989 Reduced 19.66%
118,438 $24.9 Million
Q1 2023

May 09, 2023
BUY
$191.89 - $259.92 $16 Million - $21.7 Million
83,480 Added 130.55%
147,427 $29.8 Million
Q4 2022

Feb 09, 2023
SELL
$197.11 - $250.07 $259,790 - $329,592
-1,318 Reduced 2.02%
63,947 $13.9 Million
Q3 2022

Nov 09, 2022
SELL
$182.44 - $250.54 $479,634 - $658,669
-2,629 Reduced 3.87%
65,265 $12.8 Million
Q2 2022

Aug 10, 2022
BUY
$204.13 - $302.4 $953,287 - $1.41 Million
4,670 Added 7.39%
67,894 $14.5 Million
Q1 2022

May 09, 2022
SELL
$255.51 - $362.11 $586,650 - $831,404
-2,296 Reduced 3.5%
63,224 $18 Million
Q4 2021

Feb 09, 2022
SELL
$351.38 - $448.68 $396,356 - $506,111
-1,128 Reduced 1.69%
65,520 $24.7 Million
Q3 2021

Nov 09, 2021
BUY
$372.64 - $458.3 $683,794 - $840,980
1,835 Added 2.83%
66,648 $27.5 Million
Q2 2021

Aug 10, 2021
SELL
$294.17 - $371.65 $32.1 Million - $40.5 Million
-108,955 Reduced 62.7%
64,813 $24 Million
Q1 2021

May 10, 2021
BUY
$249.67 - $299.48 $5.94 Million - $7.12 Million
23,789 Added 15.86%
173,768 $50.4 Million
Q4 2020

Feb 08, 2021
BUY
$222.0 - $252.62 $12,432 - $14,146
56 Added 0.04%
149,979 $37.5 Million
Q3 2020

Nov 06, 2020
SELL
$175.56 - $226.45 $916,598 - $1.18 Million
-5,221 Reduced 3.37%
149,923 $34 Million
Q2 2020

Aug 05, 2020
BUY
$118.84 - $189.72 $504,594 - $805,551
4,246 Added 2.81%
155,144 $27 Million
Q1 2020

May 12, 2020
SELL
$98.9 - $178.34 $6.2 Million - $11.2 Million
-62,722 Reduced 29.36%
150,898 $19 Million
Q4 2019

Feb 05, 2020
BUY
$126.05 - $152.76 $20,420 - $24,747
162 Added 0.08%
213,620 $32.6 Million
Q3 2019

Nov 13, 2019
SELL
$125.07 - $143.67 $510,285 - $586,173
-4,080 Reduced 1.88%
213,458 $28.3 Million
Q2 2019

Aug 12, 2019
BUY
$123.4 - $148.55 $297,764 - $358,451
2,413 Added 1.12%
217,538 $30.9 Million
Q1 2019

May 10, 2019
BUY
$104.82 - $146.73 $338,358 - $473,644
3,228 Added 1.52%
215,125 $31.2 Million
Q4 2018

Feb 14, 2019
SELL
$105.09 - $137.23 $469,226 - $612,731
-4,465 Reduced 2.06%
211,897 $24 Million
Q3 2018

Nov 14, 2018
BUY
$112.11 - $134.54 $387,452 - $464,970
3,456 Added 1.62%
216,362 $29.1 Million
Q2 2018

Aug 13, 2018
BUY
$102.37 - $117.25 $527,512 - $604,189
5,153 Added 2.48%
212,906 $0
Q1 2018

May 14, 2018
BUY
$98.19 - $115.2 $519,719 - $609,753
5,293 Added 2.61%
207,753 $22.2 Million
Q4 2017

Feb 13, 2018
SELL
$100.43 - $118.09 $143,614 - $168,868
-1,430 Reduced 0.7%
202,460 $22.2 Million
Q3 2017

Nov 02, 2017
BUY
$96.72 - $109.26 $19.7 Million - $22.3 Million
203,890
203,890 $22 Million

Others Institutions Holding CRL

# of Institutions
732
Shares Held
51.8M
Call Options Held
233K
Put Options Held
236K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email